Does the use of Pantodix LS lead to increased risk of fractures?
Nov 5, 2023
Does the use of Pantodix LS lead to increased risk of fractures?
Multiple studies conducted in adults have found evidence suggesting that the use of Pantodix LS may heighten the likelihood of fractures related to osteoporosis particularly in the hip wrist or spine The risk of experiencing such fractures appears to be more pronounced in individuals who have been prescribed high doses of the medication It is important to note that high dose refers to the administration of multiple daily doses over an extended period often lasting a year or longer These studies shed light on the potential implications of longterm Pantodix LS therapy emphasizing the necessity for cautious consideration of its usage particularly in patients at a higher risk of osteoporosisrelated fractures Healthcare professionals and patients alike should be aware of the potential risks associated with this medication and take appropriate measures to mitigate them While Pantodix LS might have its intended benefits its potential impact on bone health should not be overlooked Individuals who are prescribed high doses or anticipate longterm treatment should consult with their healthcare provider to assess the potential risks and benefits of continued usage This will allow for informed decisionmaking regarding the most suitable treatment options for each individual patient aiming to minimize the likelihood of osteoporosisrelated fractures